US Stem Cell Inc (USRM): U.S. Stem Cell, Inc., formerly Bioheart,...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	112
Posts	5921
Boards Moderated	1
Alias Born	01/20/2017

poor500

Re: None

Saturday, 02/01/2020 7:15:26 AM

Saturday, February 01, 2020 7:15:26 AM

U.S. Stem Cell, Inc., formerly Bioheart, Inc., is a biotechnology company. The Company is focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage. Its MyoCell is a clinical therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells, or cells from a patient's body, for the purpose of improving cardiac function in chronic heart failure patients. Its AdipoCell is a cell therapy with multiple possible treatment applications using autologous adipose cells. Its business includes the development of cell therapy products, as well as physician and patient-based regenerative medicine/cell therapy training services, and the sale of cell collection and treatment kits for humans and animals, and the operation of a cell therapy clinic. It operates through divisions, including US Stem Cell Training, Vetbiologics and US Stem Cell Clinic.
Company Contact
Headquarters
1560 Sawgrass Corporate Pkwy Fl 4
Sunrise, FL 33323-2855
http://us-stemcell.com/

Nothing I say, post, or do should ever be considered financial advice. It is just my personal opinion. I may be holding a long, short or no position. I am NOT or NEVER have been compensated to post on here and my posts are for entertainment purposes only.